Advertisement
Canada markets open in 6 hours 34 minutes

  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CAD/USD

    0.7331
    +0.0007 (+0.10%)
     

  • CRUDE OIL

    83.94
    +0.37 (+0.44%)
     

  • Bitcoin CAD

    87,888.59
    +260.73 (+0.30%)
     

  • CMC Crypto 200

    1,388.68
    -7.86 (-0.56%)
     

  • GOLD FUTURES

    2,353.00
    +10.50 (+0.45%)
     

  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • NASDAQ futures

    17,786.50
    +219.00 (+1.25%)
     

  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     

  • FTSE

    8,078.86
    +38.48 (+0.48%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6826
    +0.0005 (+0.07%)
     

Cronos Jumps Midday; Cannabis Earnings Coming Postmarket

Investing.com

Investing.com - Cannabis company Cronos Group climbed in midday trading following a multi-year deal with MediPharm Labs on cannabis and cannabis concentrate supply.

Cronos (NASDAQ:CRON) stock rose 6.5%.

The company will supply MediPharm Labs (OTC:MEDIF) with bulk cannabis for extraction use, while MediPharm will provide Cronos with about $30 million of high-quality cannabis concentrate over 18 months, Briefing.com reported.

The jump in Cronos comes ahead of earnings reports coming from two major cannabis companies after the bell.

Tilray (NASDAQ:TLRY) is forecast to post a quarterly loss of 28 cents per share, with revenue of $20.5 million. Aurora Cannabis (NYSE:ACB) is expected to lose 4 cents per share on revenue of about $52 million.

ADVERTISEMENT

Tilray rose 4%, while Aurora Cannabis gained 4.7%.

Related Articles

Israel stocks higher at close of trade; TA 35 up 1.06%

U.S. consumers sue Bumble Bee, Chicken of the Sea, StarKist over 'dolphin-safe' tuna claims

Carrefour and TerraCycle launch 'Loop' test in Paris to tackle waste